Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

A Microfluidic Platform for Single Cell Fluorometric Granzyme B Profiling.

Briones JC, Espulgar WV, Koyama S, Yoshikawa H, Park J, Naito Y, Kumanogoh A, Tamiya E, Takamatsu H, Saito M.

Theranostics. 2020 Jan 1;10(1):123-132. doi: 10.7150/thno.37728. eCollection 2020.

2.

When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).

Esquirol A, Querol S, Garcia-Cadenas I, Novelli S, Garrido A, Saavedra S, Moreno C, Granell M, Caballero A, Brunet S, Briones J, Martino R, Sierra J.

Ann Hematol. 2020 Jan;99(1):157-165. doi: 10.1007/s00277-019-03870-0. Epub 2019 Dec 17.

PMID:
31844931
3.

Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature.

García-Cadenas I, Awol R, Esquirol A, Saavedra S, Bosch-Vilaseca A, Novelli S, Garrido A, López J, Granell M, Moreno C, Briones J, Brunet S, Sierra J, Martino R.

Bone Marrow Transplant. 2019 Dec 10. doi: 10.1038/s41409-019-0771-2. [Epub ahead of print]

PMID:
31822813
4.

The Neutrophil to Lymphocyte Ratio Predicts the Response to Neoadjuvant Chemotherapy in Luminal B Breast Cancer.

Rivas M, Acevedo F, Dominguez F, Galindo H, Camus M, Oddo D, Villarroel A, Razmilic D, Peña J, Munoz Medel M, Navarro ME, Perez-Sepulveda A, Medina L, Merino T, Briones J, Kalergis A, Sanchez C.

Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2209-2212. doi: 10.31557/APJCP.2019.20.7.2209.

5.

Discussion on the indication of allogeneic stem cell transplantation for advanced cutaneous T cell lymphomas.

Novelli S, Monter A, Pilar García-Muret M, Martino R, Briones J, Sierra J.

Int J Hematol. 2019 Oct;110(4):406-410. doi: 10.1007/s12185-019-02707-w. Epub 2019 Jul 17. Review.

PMID:
31317515
6.

The curious case of the endemic freshwater crocodile Crocodylus mindorensis as incidental host of marine fish acanthocephalan.

Marcaida AJB, Urabe M, Briones JCA, Diesmos MLL, Tellez M, Diesmos AC.

Parasitol Int. 2019 Oct;72:101940. doi: 10.1016/j.parint.2019.101940. Epub 2019 Jun 12.

PMID:
31201924
7.

Silent T-cell receptor cutaneous T-cell lymphoma associated to a clonal plasma cell proliferation.

Caballero A, Novelli S, Mozos A, Muret PG, Sierra J, Briones J.

Hematol Rep. 2019 Feb 19;11(1):7841. doi: 10.4081/hr.2019.7841. eCollection 2019 Feb 19.

8.

The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma.

Escribà-Garcia L, Alvarez-Fernández C, Caballero AC, Schaub R, Sierra J, Briones J.

Oncoimmunology. 2018 Nov 26;8(2):e1546543. doi: 10.1080/2162402X.2018.1546543. eCollection 2019.

9.

Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients

Gejman R, González S, Muñoz-Medel M, Nervi B, Sánchez C, Ibáñez C, Peña J, Madrid J, Briones J, Pérez P, Garrido M, Galindo H.

Asian Pac J Cancer Prev. 2019 Jan 25;20(1):1-4.

10.

Mortality of Adult Patients With Cancer Admitted to an Intensive Care Unit in Chile: A Prospective Cohort Study.

Panay S, Ruiz C, Abarca M, Nervi B, Salazar I, Caro P, Muñiz S, Briones J, Bruhn A, Mondaca S.

J Glob Oncol. 2018 Dec;4:1-9. doi: 10.1200/JGO.18.00091.

11.

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.

Redondo AM, Valcárcel D, González-Rodríguez AP, Suárez-Lledó M, Bello JL, Canales M, Gayoso J, Colorado M, Jarque I, Del Campo R, Arranz R, Terol MJ, Rifón JJ, Rodríguez MJ, Ramírez MJ, Castro N, Sánchez A, López-Jiménez J, Montes-Moreno S, Briones J, López A, Palomera L, López-Guillermo A, Caballero D, Martín A; Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO).

Br J Haematol. 2019 Mar;184(5):797-807. doi: 10.1111/bjh.15713. Epub 2018 Dec 12.

PMID:
30548583
12.

Regorafenib adjusted dose for Chilean patients with chemoresistant metastatic colorectal cancer: a case series.

Leal JL, Briones J, Herrera ME, Müller B, Nervi B, Mondaca S.

Ecancermedicalscience. 2018 Oct 2;12:875. doi: 10.3332/ecancer.2018.875. eCollection 2018.

13.

Particle swarm optimization of nanoantenna-based infrared detectors.

Briones E, Ruiz-Cruz R, Briones J, Gonzalez N, Simon J, Arreola M, Alvarez-Alvarez G.

Opt Express. 2018 Oct 29;26(22):28484-28496. doi: 10.1364/OE.26.028484.

PMID:
30470020
14.

Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective.

Pinto MP, Muñoz Medel M, Carrillo D, Retamal IN, Bravo ML, Valenzuela Y, Nervi B, Sánchez C, Galindo H, Ibañez C, Peña J, Balmaceda C, Madrid J, Briones J, Torres J, Nilo F, Guarda FJ, Quintana JC, Orellana P, Mondaca S, Acevedo F, Vicentini D, Cordova-Delgado M, Owen GI, Garrido M.

Horm Cancer. 2019 Feb;10(1):3-10. doi: 10.1007/s12672-018-0354-5. Epub 2018 Nov 22.

15.

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma.

Baptista MJ, Tapia G, Morgades M, Muncunill J, Muñoz-Marmol AM, Montoto S, Gribben JG, Calaminici M, Martinez A, Gonzalez-Farre B, Dlouhy I, González-Barca E, Terol MJ, Miralles P, Alcoceba M, Vall-Llovera F, Briones J, Abrisqueta P, Abella E, Provencio M, García-Ballesteros C, Moraleda JM, Sancho JM, Ribera JM, Mate JL, Navarro JT.

Leuk Lymphoma. 2019 Apr;60(4):1087-1091. doi: 10.1080/10428194.2018.1512711. Epub 2018 Oct 15. No abstract available.

PMID:
30322315
16.

Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy.

Vicente EP, Cuellar-García C, Martinez M, Soler A, Mora A, Bosch R, Brunet S, Briones J, García I, Esquirol A, Granell M, Saavedra S, Nomdedeu J, Sierra J, Martino R, Moreno C.

Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):737-742. doi: 10.1016/j.clml.2018.06.023. Epub 2018 Jun 27.

PMID:
30017595
17.

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.

Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu F, Ordóñez GR, Rovira J, Clot G, Royo C, Navarro A, Gonzalez-Farre B, Vaghefi A, Castellano G, Rubio-Perez C, Tamborero D, Briones J, Salar A, Sancho JM, Mercadal S, Gonzalez-Barca E, Escoda L, Miyoshi H, Ohshima K, Miyawaki K, Kato K, Akashi K, Mozos A, Colomo L, Alcoceba M, Valera A, Carrió A, Costa D, Lopez-Bigas N, Schmitz R, Staudt LM, Salaverria I, López-Guillermo A, Campo E.

Leukemia. 2018 Mar;32(3):675-684. doi: 10.1038/leu.2017.251. Epub 2017 Aug 14.

18.

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.

Escribà-Garcia L, Alvarez-Fernández C, Tellez-Gabriel M, Sierra J, Briones J.

J Transl Med. 2017 May 26;15(1):115. doi: 10.1186/s12967-017-1219-3.

19.

Do Patients and Physicians Agree When They Assess Quality of Life?

Barata A, Martino R, Gich I, García-Cadenas I, Abella E, Barba P, Briones J, Brunet S, Esquirol A, García-Pallarols F, Garrido A, Granell M, Martinez J, Mensa I, Novelli S, Sánchez-González B, Valcárcel D, Sierra J.

Biol Blood Marrow Transplant. 2017 Jun;23(6):1005-1010. doi: 10.1016/j.bbmt.2017.03.015. Epub 2017 Mar 10.

20.

Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.

Picleanu AM, Novelli S, Monter A, Garcia-Cadenas I, Caballero AC, Martino R, Esquirol A, Briones J, Sierra J.

Ann Hematol. 2017 May;96(5):787-796. doi: 10.1007/s00277-017-2934-9. Epub 2017 Feb 6.

PMID:
28168350
21.

Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial.

Magnano L, Montoto S, González-Barca E, Briones J, Sancho JM, Muntañola A, Salar A, Besalduch J, Escoda L, Moreno C, Domingo-Domenech E, Estany C, Oriol A, Altés A, Pedro C, Gardella S, Asensio A, Vivancos P, Fernández de Sevilla A, Ribera JM, Colomer D, Campo E, López-Guillermo A.

Ann Hematol. 2017 Apr;96(4):639-646. doi: 10.1007/s00277-017-2920-2. Epub 2017 Jan 18.

PMID:
28101592
22.

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Genadieva-Stavrik S, Boumendil A, Dreger P, Peggs K, Briones J, Corradini P, Bacigalupo A, Socié G, Bonifazi F, Finel H, Velardi A, Potter M, Bruno B, Castagna L, Malladi R, Russell N, Sureda A.

Ann Oncol. 2016 Dec;27(12):2251-2257. doi: 10.1093/annonc/mdw421. Epub 2016 Oct 24.

23.

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial.

Cabrero M, Martin A, Briones J, Gayoso J, Jarque I, López J, Grande C, Heras I, Arranz R, Bernal T, Perez-Lopez E, López-Godino O, Conde E, Caballero D.

Biol Blood Marrow Transplant. 2017 Jan;23(1):53-59. doi: 10.1016/j.bbmt.2016.10.003. Epub 2016 Oct 19.

24.

Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease.

García-Cadenas I, Rivera I, Martino R, Esquirol A, Barba P, Novelli S, Orti G, Briones J, Brunet S, Valcarcel D, Sierra J.

Bone Marrow Transplant. 2017 Jan;52(1):107-113. doi: 10.1038/bmt.2016.225. Epub 2016 Sep 5.

PMID:
27595281
25.

A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.

Alvarez-Fernández C, Escribà-Garcia L, Vidal S, Sierra J, Briones J.

J Transl Med. 2016 Jul 19;14(1):214. doi: 10.1186/s12967-016-0973-y.

26.

Expedient synthesis of tetrahydroquinoline-3-spirohydantoin derivatives via the Lewis acid-catalyzed tert-amino effect reaction.

Briones JF, Basarab GS.

Chem Commun (Camb). 2016 Jun 30;52(55):8541-4. doi: 10.1039/c6cc03600g.

PMID:
27314439
27.

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.

González-Barca E, Canales MA, Salar A, Ferrer S, Domingo-Domenech E, Vidal MJ, Grande C, Bargay J, Gardella S, Oriol A, Briones J, García-Frade J, Bello JL, Sánchez-Blanco JJ, Peñalver FJ, Tomás JF, Asensio A, López A, Caballero D; GELTAMO Group (Grupo Español de Linfoma y Trasplante de Médula Ósea).

Acta Haematol. 2016;136(2):76-84. doi: 10.1159/000444625. Epub 2016 May 18.

PMID:
27188649
28.

Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.

Martínez C, Díaz-López A, Rodriguez-Calvillo M, García-Sanz R, Terol MJ, Pérez-Ceballos E, Jiménez MJ, Cantalapiedra A, Domingo-Domenech E, Rodriguez MJ, Sampol A, Espeso M, López FJ, Briones J, García JF, Sureda A; Hodgkin Lymphoma Subcommittee of Spanish Group of Lymphoma Bone Marrow Transplantation(GELTAMO).

Br J Haematol. 2016 Sep;174(6):859-67. doi: 10.1111/bjh.14133. Epub 2016 May 17.

PMID:
27185197
29.

Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome.

Novelli S, García-Muret P, Mozos A, Sierra J, Briones J.

Leuk Lymphoma. 2016 May;57(5):1060-6. doi: 10.3109/10428194.2015.1057894. Epub 2016 Jan 11.

PMID:
27096891
30.

Alemtuzumab treatment for Sézary syndrome: A single-center experience.

Novelli S, García-Muret P, Sierra J, Briones J.

J Dermatolog Treat. 2016;27(2):179-81. doi: 10.3109/09546634.2015.1086479. Epub 2015 Sep 25.

PMID:
26329989
31.

Vegetation exerts a greater control on litter decomposition than climate warming in peatlands.

Ward SE, Orwin KH, Ostle NJ, Briones JI, Thomson BC, Griffiths RI, Oakley S, Quirk H, Bardget RD.

Ecology. 2015 Jan;96(1):113-23.

PMID:
26236896
32.

PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.

Novelli S, Briones J, Flotats A, Sierra J.

Adv Clin Exp Med. 2015 Mar-Apr;24(2):325-30. doi: 10.17219/acem/31804.

33.

Heat-shock proteins: a c-Myc lymphoma target?

Briones J.

Blood. 2015 Mar 12;125(11):1685-6. doi: 10.1182/blood-2015-01-622191. No abstract available.

PMID:
25766562
34.

Seebeck nanoantennas for the detection and characterization of infrared radiation.

Briones E, Cuadrado A, Briones J, Díaz de León R, Martínez-Antón JC, McMurtry S, Hehn M, Montaigne F, Alda J, González FJ.

Opt Express. 2014 Oct 20;22 Suppl 6:A1538-46. doi: 10.1364/OE.22.0A1538.

PMID:
25607310
35.

New therapies in non-Hodgkin lymphoma.

Novelli S, Sierra J, Briones J.

Expert Rev Anticancer Ther. 2015 Mar;15(3):349-59. doi: 10.1586/14737140.2015.1002773. Epub 2015 Jan 12. Review.

PMID:
25582186
36.

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.

García-Cadenas I, Castillo N, Martino R, Barba P, Esquirol A, Novelli S, Orti G, Garrido A, Saavedra S, Moreno C, Granell M, Briones J, Brunet S, Navarro F, Ruiz I, Rabella N, Valcárcel D, Sierra J.

Bone Marrow Transplant. 2015 Apr;50(4):579-84. doi: 10.1038/bmt.2014.298. Epub 2015 Jan 12.

PMID:
25581404
37.

Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute.

Rule S, Briones J, Smith R, Theodore OC, Ngoh CA, Osborne S, Capochiani E, Rummel M.

Value Health. 2014 Nov;17(7):A537. doi: 10.1016/j.jval.2014.08.1719. Epub 2014 Oct 26. No abstract available.

38.

[Active surveillance in prostate cancer. Introduction].

Briones JR.

Arch Esp Urol. 2014 Jun;67(5):367-8. Spanish. No abstract available.

PMID:
25039087
39.

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.

Briones J, Novelli S, García-Marco JA, Tomás JF, Bernal T, Grande C, Canales MA, Torres A, Moraleda JM, Panizo C, Jarque I, Palmero F, Hernández M, González-Barca E, López D, Caballero D; Grupo Español de Linfomas y Trasplante Autologo de Médula Ósea (GELTAMO).

Haematologica. 2014 Jul;99(7):e126. doi: 10.3324/haematol.2014.108308. No abstract available.

40.

Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation.

García Cadenas I, Valcarcel D, Martino R, Piñana JL, Barba P, Novelli S, Esquirol A, Garrido A, Saavedra S, Granell M, Moreno C, Briones J, Brunet S, Sierra J.

Mediators Inflamm. 2014;2014:620682. doi: 10.1155/2014/620682. Epub 2014 Jan 30.

41.

Focal adhesion protein expression in human diffuse large B-cell lymphoma.

Bosch R, Dieguez-Gonzalez R, Moreno MJ, Gallardo A, Novelli S, Espinosa I, Céspedes MV, Pavón MÁ, Briones J, Grañena A, Sierra J, Mangues R, Casanova I.

Histopathology. 2014 Jul;65(1):119-31. doi: 10.1111/his.12381. Epub 2014 Apr 3.

PMID:
24467224
42.

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia.

Briones J, Iruretagoyena M, Galindo H, Ortega C, Zoroquiain P, Valbuena J, Acevedo F, Ocqueteau M, Sánchez C.

Ecancermedicalscience. 2013 Oct 17;7:364. doi: 10.3332/ecancer.2013.364. eCollection 2013.

43.

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.

Briones J, Novelli S, García-Marco JA, Tomás JF, Bernal T, Grande C, Canales MA, Torres A, Moraleda JM, Panizo C, Jarque I, Palmero F, Hernández M, González-Barca E, López D, Caballero D; GELTAMO.

Haematologica. 2014 Mar;99(3):505-10. doi: 10.3324/haematol.2013.093450. Epub 2013 Oct 25.

44.

Direct spectroscopic characterization of a transitory dirhodium donor-acceptor carbene complex.

Kornecki KP, Briones JF, Boyarskikh V, Fullilove F, Autschbach J, Schrote KE, Lancaster KM, Davies HM, Berry JF.

Science. 2013 Oct 18;342(6156):351-4. doi: 10.1126/science.1243200. Epub 2013 Sep 12.

45.

Enantioselective Gold(I)-catalyzed vinylogous [3 + 2] cycloaddition between vinyldiazoacetates and enol ethers.

Briones JF, Davies HM.

J Am Chem Soc. 2013 Sep 11;135(36):13314-7. doi: 10.1021/ja407179c. Epub 2013 Aug 28.

PMID:
23978108
46.

Fatal strongyloides hyperinfection complicating a gram-negative sepsis after allogeneic stem cell transplantation: a case report and review of the literature.

Izquierdo I, Briones J, Lluch R, Arqueros C, Martino R.

Case Rep Hematol. 2013;2013:860976. doi: 10.1155/2013/860976. Epub 2013 Jul 10.

48.

LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas.

Bertolo C, Roa S, Sagardoy A, Mena-Varas M, Robles EF, Martinez-Ferrandis JI, Sagaert X, Tousseyn T, Orta A, Lossos IS, Amar S, Natkunam Y, Briones J, Melnick A, Malumbres R, Martinez-Climent JA.

Br J Haematol. 2013 Sep;162(5):621-30. doi: 10.1111/bjh.12440. Epub 2013 Jun 25.

49.

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Valera A, López-Guillermo A, Cardesa-Salzmann T, Climent F, González-Barca E, Mercadal S, Espinosa I, Novelli S, Briones J, Mate JL, Salamero O, Sancho JM, Arenillas L, Serrano S, Erill N, Martínez D, Castillo P, Rovira J, Martínez A, Campo E, Colomo L; Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB).

Haematologica. 2013 Oct;98(10):1554-62. doi: 10.3324/haematol.2013.086173. Epub 2013 May 28.

50.

Epidemiology of lymphoid malignancies: last decade update.

Novelli S, Briones J, Sierra J.

Springerplus. 2013 Dec;2(1):70. doi: 10.1186/2193-1801-2-70. Epub 2013 Feb 26.

Supplemental Content

Loading ...
Support Center